The results of a recent compound screening effort to identify inhibitors of tau inclusion formation in primary rat cortical neurons seeded with AD-tau (Gibbons et al., 2023) revealed two compounds with reported HDAC6 inhibitory activity, UF010 and BRD73954, both of which caused a concentration-dependent inhibition of neuronal tau aggregates. This evidence concerns the gene MAPT and Alzheimer disease.